Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis

Oncogene

Volumn 24, Issue 9, 2005, Pages 1634-1640

  Corcoran, Chad A ^a   He, Qin ^a   Huang, Ying ^a   Saeed Sheikh, M ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Apoptosis; COX 2; NSAIDs; p53; Transcription

Indexed keywords

CYCLOOXYGENASE 2; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOPLASM; ENZYME INHIBITION; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; WILD TYPE; BREAST TUMOR; FEMALE; GENETIC TRANSCRIPTION; GENETICS; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; FEMALE; GENES, P53; HUMANS; MALE; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTATIC NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 14944379632     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208353     Document Type: Article

References (35)

1. Alarcon-Vargas D and Ronai Z. (2002). Carcinogenesis, 23, 541-547.
2. Corcoran CA, Huang Y and Sheikh MS. (2004). Cancer Biol. Ther., 3, 721-725.
3. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H and Dixit VM. (2004). Nature, 429, 86-92.
4. Gallo O, Schiavone N, Papucci L, Sardi I, Magnelli L, Franchi A, Masini E and Capaccioli S. (2003). Am. J. Pathol., 163, 723-732.
5. Giaccia AJ and Kastan MB. (1998). Genes Dev., 12, 2973-2983.
6. Grewal S, Ponnambalam S and Walker JH. (2003). J. Cell. Sci., 116, 2303-2310.
7. Grosch S, Tegeder I, Niederberger E, Brautigam L and Geisslinger G. (2001). FASEB J., 15, 2742-2744.
8. Han J, Flemington C, Houghton AB, Gu Z, Zambetti GP, Lutz RJ, Zhu L and Chittenden T. (2001). Proc. Natl. Acad. Sci. USA, 98, 11318-11323.
9. Han JA, Kim JI, Ongusaha PP, Hwang DH, Ballou LR, Mahale A, Aaronson SA and Lee SW. (2002). EMBO J., 21, 5635-5644.
10. Hofseth LJ, Hussain SP and Harris CC. (2004). Trends Pharmacol Sci., 25, 177-181.
11. Huang Y, He Q, Hillman MJ, Rong R and Sheikh MS. (2001). Cancer Res., 61, 6918-6924.
12. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA and Prescott SM. (1993). J. Biol. Chem., 268, 9049-9054.
13. Kulp SK, Yang YT, Hung CC, Chen KF, Lai JP, Tseng PH, Fowble JW, Ward PJ and Chen CS. (2004). Cancer Res., 64, 1444-1451.
14. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R and Benchimol S. (2003). Cell, 112, 779-791.
15. Liou JY, Deng WG, Gilroy DW, Shyue SK and Wu KK. (2001). J. Biol. Chem., 276, 34975-34982.
16. Lloyd DR and Hanawalt PC. (2002). Cancer Res., 62, 5288-5294.
17. Luo X, Huang Y and Sheikh MS. (2003). Oncogene, 22, 7247-7257.
18. Majumder M, Ghosh AK, Steele R, Ray R and Ray RB. (2001). J. Virol., 75, 1401-1407.
19. Morita I, Schindler M, Regier MK, Otto JC, Hori T, DeWitt DL and Smith WL. (1995). J. Biol. Chem., 270, 10902-10908.
20. Nakano K and Vousden KH. (2001). Mol. Cell, 7, 683-694.
21. Nikolaev AY, Li M, Puskas N, Qin J and Gu W. (2003). Cell, 112, 29-40.
22. Seo YR, Fishel ML, Amundson S, Kelley MR and Smith ML. (2002). Oncogene, 21, 731-737.
23. Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, Fornace Jr AJ and el-Deiry WS. (1998). Cancer Res., 58, 1593-1598.
24. Sheikh MS and Fornace Jr AJ. (2000). J. Cell Physiol., 182, 171-181.
25. Shureiqi I, Xu X, Chen D, Lotan R, Morris JS, Fischer SM and Lippman SM. (2001). Cancer Res., 61, 4879-4884.
26. Smigel K. (2000). J. Natl. Cancer Inst., 92, 297-299.
27. Spencer AG, Woods JW, Arakawa T, Singer II and Smith WL. (1998). J. Biol. Chem., 273, 9886-9893.
28. Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A and Dannenberg AJ. (1999). J. Biol. Chem., 274, 10911-10915.
29. Swamy MV, Herzog CR and Rao CV. (2003). Cancer Res., 63, 5239-5242.
30. Thun MJ, Henley SJ and Partrono C. (2002). J. Natl. Cancer Inst., 94, 252-266.
31. Trifan OC, Smith RM, Thompson BD and Hla T. (1999). J. Biol. Chem., 274, 34141-34147.
32. Wang W and El-Deiry WS. (2003). Cancer Biol. Ther., 2, 196-202.
33. Williams CS, Mann M and DuBois RN. (1999). Oncogene, 18, 7908-7916.
34. Yu J, Zhang L, Hwang PM, Kinzler KW and Vogelstein B. (2001). Mol. Cell, 7, 673-682.
35. Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW and Vogelstein B. (1999). Proc. Natl. Acad. Sci. USA, 96, 14517-14522.